Effect of erythropoietin on oxygen-induced brain injury in the newborn rat

Neuroscience Letters

Volumn 448, Issue 3, 2008, Pages 245-249

  Yiş, Uluç ^a   Kurul, Semra Hiz ^a   Kumral, Abdullah ^a   Tuǧyan, Kazim ^a   Cilaker, Serap ^a   Yilmaz, Osman ^a   Genç, Şermin ^a   Genç, Kürşat ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

Apoptosis; Brain; Erythropoietin; Hyperoxia; Newborn; Rat

Indexed keywords

ERYTHROPOIETIN; OXYGEN; RECOMBINANT ERYTHROPOIETIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN DEVELOPMENT; BRAIN INJURY; BRAIN REGION; CONTROLLED STUDY; DRUG EFFECT; HISTOPATHOLOGY; HYPEROXIA; NERVE CELL; NERVE DEGENERATION; NEUROPROTECTION; NEWBORN; NONHUMAN; OXYGEN CONCENTRATION; PRIORITY JOURNAL; RAT;

ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; BRAIN; BRAIN DISEASES; DENTATE GYRUS; DNA FRAGMENTATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; ERYTHROPOIETIN, RECOMBINANT; HIPPOCAMPUS; HYPEROXIA; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; NEUROPROTECTIVE AGENTS; OXYGEN; PARIETAL LOBE; RATS; RATS, WISTAR;

EID: 56249103763     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2008.10.060     Document Type: Article

References (35)

1. Arkovitz M.S., Szabo C., Garcia V.F., Wong H.R., and Wispe J.R. Differential effects of hyperoxia on the inducible and constitutive isoforms of nitric oxide synthase in the lung. Shock 7 (1997) 345-350
2. Brines M., and Cerami A. Emerging biological roles for erythropoietin in the nervous system. Nat. Rev. Neurosci. 6 (2005) 484-494
3. Brines M.L., Ghezzi P., Kenan S., Agnello D., de-Lanerolle N.C., Cerami C., Itri L.M., and Ghezzi P. Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 10526-10531
4. Buonocore G., and Groenendaal F. Anti-oxidant strategies. Semin. Fetal Neonatal. Med. 12 (2007) 287-295
5. Chong Z.Z., Lin S.H., Kang J.Q., and Maiese K. Erythropoietin prevents early and late neuronal demise through modulation of Akt1 and induction of caspase 1, 3, and 8. J. Neurosci. Res. 71 (2003) 659-669
6. Collins M.P., Lorenz J.M., Jetton J.R., and Paneth N. Hypocapnia and other ventilation-related risk factors for cerebral palsy in low birth weight infants. Pediatr. Res. 50 (2001) 712-719
7. Digicaylioglu M., and Lipton S.A. Erythropoietin-mediated neuroprotection involves cross-talk between JaK2 and NF-kappaB signalling cascades. Nature 412 (2001) 641-647
8. Dobbing J., Sands J., and Gratrix C.A. Cell size and cell number: a reconsideration of organ growth and catch-up potential. Proc. Nutr. Soc. 98 (1979) 99A
9. Ehrenreich H., Aust C., Krampe H., Jahn H., Jacob S., Herrmann M., and Siren A.L. Erythropoeitein: novel approaches to neuroprotection in human brain disease. Met. Brain Dis. 19 (2004) 195-206
10. Felderhoff-Mueser U., Bittigau P., Sifringer M., Jarosz B., Korobowicz E., Mahler L., Piening T., Moysich A., Grune T., Thor F., Heumann R., Bührer C., and Ikonomidou C. Oxygen causes cell death in the developing brain. Neurobiol. Dis. 17 (2004) 273-282
11. Felderhoff-Mueser U., Sifringer M., Polley O., Dzietko M., Leineweber B., Mahler L., Baier M., Bittigau P., Obladen M., Ikonomidou C., and Bührer C. Caspase-1-processed interleukins in hyperoxia-induced cell death in the developing brain. Ann. Neurol. 57 (2005) 50-59
12. Genc S., Koroglu T.F., and Genc K. Erythropoietin as a novel neuroprotectant. Restor. Neurol. Neurosci. 22 (2004) 105-119
13. Gerstner B., DeSilva T.M., Genz K., Armstrong A., Brehmer F., Neve R.L., Felderhoff-Mueser U., Volpe J.J., and Rosenberg P.A. Hyperoxia causes maturation-dependent cell death in the developing white matter. J. Neurosci. 28 (2008) 1236A-1245A
14. Ghezzi P., and Brines M. Erythropoietin as an antiapoptotic, tissueprotective cytokine. Cell Death Differ. 11 Suppl. 1 (2004) S37-S44
15. Gorio A., Madaschi L., Di Stefano B., Carelli S., Di Giulio A.M., De Biasi S., Coleman T., Cerami A., and Brines M. Methylprednisolone neutralizes the beneficial effects of erythropoietin in experimental spinal cord injury. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 16379-16384
16. Hintz S.R., Kendrick D.E., Vohr B.R., Poole W.K., and Higgins R.D. National Institute of Child Health and Human Development Neonatal Research Network. Changes in neurodevelopmental outcomes at 18 to 22 months corrected age among infants of less than 25 weeks gestational age born in 1993-1999. Pediatrics 115 (2005) 1645-1651
17. Hu X., Qiu J., Grafe M.R., Rea H.C., Rassin D.K., and Perez-Polo J.R. Bcl-2 family members make different contributions to cell death in hypoxia and/or hyperoxia in rat cerebral cortex. Int. J. Dev. Neurosci. 371 (2003) 371-377
18. Ishikawa Y., Satoh T., Enokido Y., Nishio C., Ikeuchi T., and Hatanaka H. Generation of reactive oxygen species, release of l-glutamate and activation of caspases are required for oxygen induced apoptosis of embryonic hippocampal neurons in culture. Brain Res. 824 (1999) 71-80
19. Jelkmann W. Erythropoietin: structure, control of production, and function. Physiol. Rev. 72 (1992) 449-489
20. Juul S.E., Yachnis A.T., Rojiani A.M., and Christensen R.D. Immunohistochemical localization of erythropoietin and its receptor in the developing human brain. Pediatr. Dev. Pathol. 2 (1999) 148-158
21. Koch J.D., Miles D.K., Gilley J.A., Yang C.P., and Kernie S.G. Brief exposure to hyperoxia depletes the glial progenitor pool and impairs functional recovery after hypoxic-ischemic brain injury. J. Cereb. Blood Flow Metab. 28 (2008) 1294-1306
22. Kumral A., Baskin H., Yesilirmak D.C., Ergur B.U., Aykan S., Genc S., Yi{dotless}lmaz O., Giray O., Duman N., and Özkan H. Erythropoietin attenuates lipopolysaccharide-induced white matter injury in the neonatal rat brain. Neonatology 92 (2007) 269-278
23. Liu J., Narasimhan P., Song Y.S., Nishi T., Yu F., Lee Y.S., and Chan P.H. Epo protects SOD2-deficient mouse astrocytes from damage by oxidative stress. Glia 53 (2006) 360-365
24. Marti H.H., Wenger R.H., Rivas L.A., Straumann U., Digicaylioglu M., Henn V., Yonekawa Y., Bauer C., and Gassmann M. Erythropoietin gene expression in human, monkey and murine brain. Eur. J. Neurosci. 8 (1996) 666-676
25. Morishita E., Masuda S., Nagao M., Yasuda Y., and Sasaki R. Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death. Neuroscience 76 (1997) 105-116
26. Ovbiagele B., Kidwell C.S., Starkman S., and Saver J.L. Potential role of neuroprotective agents in the treatment of patients with acute ischemic stroke. Curr. Treat. Options Neurol. 5 (2003) 367-375
27. Paxinos G., and Watson C. Thr Rat Brain in Stereotaxic Coordinates. 2nd ed. (1986), Academic Press, New York
28. Sakanaka M., Wen T.C., Matsuda S., Masuda S., Morishita E., Nagao M., and Sasaki R. In vivo evidence that erythropoietin protects neurons from ischemic damage. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 4635-4640
29. Sennlaub F., Courtois Y., and Goureau O. Inducible nitric oxide synthase mediates the change from retinal to vitreal neovascularization in ischemic retinopathy. J. Clin. Invest. 107 (2001) 717-725
30. Sirinyan M., Sennlaub F., Dorfman A., Sapieha P., Gobeil Jr. F., Hardy P., Lachapelle P., and Chemtob S. Hyperoxic exposure leads to nitrative stress and ensuing microvascular degeneration and diminished brain mass and function in the immature subject. Stroke 37 (2006) 2807-2815
31. Sola A., Rogido M.R., and Deulofeut R. Oxygen as a neonatal health hazard: call for détente in clinical practice. Acta Paediatr. 96 (2007) 801-812
32. van der Kooij M.A., Groenendaal F., Kavelaars A., Heijnen C.J., and van Be F. Neuroprotective properties and mechanisms of erythropoietin in in vitro and in vivo experimental models for hypoxia/ischemia. Brain Res. Rev. (2008) (Epub ahead of print)
33. Viviani B., Bartesaghi S., Corsini E., Villa P., Ghezzi P., Garau A., Gali C.L., and Mainovich M. Erythropoietin protects primary hippocampal neurons increasing the expression of brain-derived neurotrophic factor. J. Neurochem. 93 (2005) 412-421
34. Wang L., Zhang Z., Wang Y., Zhang R., and Chopp M. Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats. Stroke 35 (2004) 1732-1737
35. Yis U., Kurul S.H., Kumral A., Cilaker S., Tugyan K., Genc S., and Yi{dotless}lmaz O. Hyperoxic exposure leads to cell death in the developing brain. Brain Dev. (2008) (Epub ahead of print)